| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Margaret Smith Bell is Director at TNXP. Margaret Smith Bell's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Margaret Smith Bell has 11 Form 4 filings on record from June 2018 to May 2026, all as Director at Tonix Pharmaceuticals (TNXP), 2018–2026.
The 11 reported transactions were 9 option or other derivative awards, 1 other transaction and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $5K and no sales.
The only open-market purchase was 5,391 shares of TNXP at an average $0.93 on August 20, 2020, about $5K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2020 | TNXP Tonix Pharmaceuticals Holding Corp. | Director | Buy | 5,391 | $0.93 | $4,997.46 | New |